Adempas Tablet, Film Coated
Product Images NDC 50419-252

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Adempas (NDC 50419-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (E9e1a668 1b31 4094 88b7 2004f94af53d 01)

FDA Label Image

Effect Of Intrinsic Factors On Riociguat And M1 Pharmacokinetics (E9e1a668 1b31 4094 88b7 2004f94af53d 02)

FDA Label Image

Figure 2: Effect Of Extrinsic Factors On Riociguat And M1 Pharmacokinetics (E9e1a668 1b31 4094 88b7 2004f94af53d 03)

This text appears to be a list of medications and substances, along with recommendations for potential interactions with other drugs or supplements. The list includes various strong and moderate inhibitors and inducers, as well as antacids, antiplatelet agents, and more. The specific details of the recommendations are difficult to decipher without further context, but it appears that some medications may require dose adjustments or separate administration to avoid potential negative interactions.*

FDA Label Image

Chest-1 Mean Change From Baseline In The 6-minute Walk (E9e1a668 1b31 4094 88b7 2004f94af53d 04)

FDA Label Image

Figure 5: Mean Treatment Difference In Change From Baseline To Last Visit In 6-minute Walk Distance (meters) By Prespecified Subgroups (E9e1a668 1b31 4094 88b7 2004f94af53d 06)

FDA Label Image

Patent-1 Mean Change From Baseline In The 6-minute Walk Distance (E9e1a668 1b31 4094 88b7 2004f94af53d 07)

FDA Label Image

Patent-1 Distribution Of Patients By Change From Baseline In 6-minute Walk Distan (E9e1a668 1b31 4094 88b7 2004f94af53d 08)

FDA Label Image

Patent-1 Mean Treatment Difference In Change From Baseline To Last Visit In 6-minute Walk Distance (meter) By Prespecified Subgroups (E9e1a668 1b31 4094 88b7 2004f94af53d 09)

FDA Label Image

Patent-1 Time (in Days) To Clinical Worsening (itt Analysis Set) (E9e1a668 1b31 4094 88b7 2004f94af53d 10)

FDA Label Image

Birth Control Methods (E9e1a668 1b31 4094 88b7 2004f94af53d 11)

FDA Label Image

.5 Carton (E9e1a668 1b31 4094 88b7 2004f94af53d 12)

Adempas is a medication that comes in tablet form, containing Riociguat. The dosage should be strictly followed, and it needs to be stored at 25 degree Celsius. It is a prescription drug, and the details about the drug, such as composition and storage, are provided on the carton. The provided text contains some distortion; might have not read it correctly.*

FDA Label Image

1 Carton (E9e1a668 1b31 4094 88b7 2004f94af53d 13)

FDA Label Image

1.5 Carton (E9e1a668 1b31 4094 88b7 2004f94af53d 14)

FDA Label Image

2 Carton (E9e1a668 1b31 4094 88b7 2004f94af53d 15)

This is a description of a medication called Adempas, which comes in tablet form. The tablets are available in a strength of 2mg per tablet and are embossed with the code "PR S2277060". The medication contains riociguat and is used to treat pulmonary arterial hypertension. The label on the packaging mentions that the tablets are varnish-free, but there is no information available on what this means.*

FDA Label Image

2.5 Carton (E9e1a668 1b31 4094 88b7 2004f94af53d 16)

This text contains information on a medicine called Adempas (riociguat) tablets. Each container has 30 soluble tablets, containing 25 mg of riociguat per tablet. The recommended dosage is to take one tablet three times daily. Storage instructions advise keeping the medicine at room temperature (25-77 F) and protecting it from light. The text also includes various product codes and references to a "VARNISH FREE" feature, but it is unclear how this relates to the medicine itself.*

FDA Label Image

Figure 4: Chest-1 Distribution Of Patients By Change From Baseline In 6-minute Walk Distance (Image 01)

This seems to be a table or chart depicting the change in 6-minute walk distance in some sort of study or experiment. The text also includes the words "Improvement" and "Worsening" which likely indicate the direction of change in the participants' walking ability. However, the rest of the text appears to be a mix of letters, numbers, and symbols that cannot be interpreted as readable language.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.